#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2037944	Functional	Agonist activity at human recombinant GPR109a expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation	Homo sapiens	37	ALA2034879	cell-based format	Scientific Literature
2.	ALA2037945	Functional	Agonist activity at human GPR109b	Homo sapiens	7	ALA2034879	assay format	Scientific Literature
3.	ALA2037946	Functional	Agonist activity at rat GPR109a	Rattus norvegicus	7	ALA2034879	assay format	Scientific Literature
4.	ALA2037947	Functional	Agonist activity at mouse GPR109a	Mus musculus	7	ALA2034879	assay format	Scientific Literature
5.	ALA2037948	Functional	Agonist activity at dog GPR109a	Canis lupus familiaris	7	ALA2034879	assay format	Scientific Literature
6.	ALA2037949	Functional	Antidyslipidemic activity in fasted Sprague-Dawley rat assessed as reduction in free fatty acid level in plasma at 1 mg/kg, po after 1 hr relative to vehicle-treated control	Rattus norvegicus	5	ALA2034879	organism-based format	Scientific Literature
7.	ALA2037950	Functional	Antidyslipidemic activity in fasted Sprague-Dawley rat assessed as reduction in triglyceride level in plasma at 1 mg/kg, po after 1 hr relative to vehicle-treated control	Rattus norvegicus	5	ALA2034879	organism-based format	Scientific Literature
8.	ALA2037955	Functional	Antidyslipidemic activity in fasted beagle dog assessed as reduction in free fatty acid level in plasma at 1 mg/kg, po after 1 hr relative to vehicle-treated control	Canis lupus familiaris	3	ALA2034879	organism-based format	Scientific Literature
9.	ALA2038314	ADME	AUC (0 to 24 hrs) in Sprague-Dawley rat at 5 mg/kg, po	Rattus norvegicus	1	ALA2034879	organism-based format	Scientific Literature
10.	ALA2038315	ADME	Oral bioavailability in Sprague-Dawley rat at 5 mg/kg	Rattus norvegicus	1	ALA2034879	organism-based format	Scientific Literature
11.	ALA2038316	Functional	Antidyslipidemic activity in po dosed fasted Sprague-Dawley rat assessed as reduction in free fatty acid level in plasma	Rattus norvegicus	2	ALA2034879	organism-based format	Scientific Literature
12.	ALA2038317	Functional	Antidyslipidemic activity in po dosed fasted Sprague-Dawley rat assessed as reduction in triglyceride level in plasma	Rattus norvegicus	1	ALA2034879	organism-based format	Scientific Literature
13.	ALA2038318	Functional	Antidyslipidemic activity in fasted Sprague-Dawley rat assessed as reduction in free fatty acid level in plasma at 3 mg/kg, po up to 2 hrs	Rattus norvegicus	1	ALA2034879	organism-based format	Scientific Literature
14.	ALA2038319	Functional	Antidyslipidemic activity in fasted Sprague-Dawley rat assessed as reduction in free fatty acid level in plasma at 3 mg/kg, po after 2 hrs	Rattus norvegicus	1	ALA2034879	organism-based format	Scientific Literature
15.	ALA2038320	Toxicity	Toxicity in fasted beagle dog assessed as flushing at 1 to 10 mg/kg, po	Canis lupus familiaris	1	ALA2034879	organism-based format	Scientific Literature
16.	ALA2038321	Toxicity	Toxicity in fasted beagle dog assessed as change in skin colour at 1 to 10 mg/kg, po	Canis lupus familiaris	1	ALA2034879	organism-based format	Scientific Literature
17.	ALA2038322	Toxicity	Toxicity in fasted beagle dog assessed as behavioural changes at 1 to 10 mg/kg, po	Canis lupus familiaris	1	ALA2034879	organism-based format	Scientific Literature
18.	ALA2038323	Toxicity	Toxicity in fasted beagle dog assessed as increase in cutaneous blood flow at 30 mg/kg, po relative to control	Canis lupus familiaris	1	ALA2034879	organism-based format	Scientific Literature
19.	ALA2038324	Toxicity	Toxicity in fasted beagle dog assessed as behavioural changes at 30 mg/kg, po relative to control	Canis lupus familiaris	1	ALA2034879	organism-based format	Scientific Literature
20.	ALA2038325	Toxicity	Nephrotoxicity in CD1 mouse at 100 mg/kg, po administered qd for 5 days measured 2 hrs post-last dose	Mus musculus	1	ALA2034879	organism-based format	Scientific Literature